Skip to main content
Home
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor/Perspectives
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
Subscribe
Home
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor/Perspectives
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
FDA Oncology Update
Atezolizumab Approved for Patients with Advanced or Metastatic Urothelial Carcinoma
Read More
Nivolumab Approved for Patients with Relapsed, Refractory Classical Hodgkin Lymphoma
Read More
Netspot Approved for Detection of Neuroendocrine Tumors
Read More
First EGFR Mutation Blood Test Approved for Patients with NSCLC
Read More
Monthly Injection Approved for Patients with Relapsed Multiple Sclerosis
Read More
Pembrolizumab Approved for Patients with Head and Neck Cancer
Read More
Daratumumab Combination Approved for Multiple Myeloma
Read More
FDA Approves Rucaparib and Companion Diagnostic for Patients with Advanced Ovarian Cancer
Read More
FDA News - January 2017
Read More
FDA News - April 2017
Read More
1
2
3
4
5
6
7
Page 4 of 26
Results 31 - 40 of 253